Forbes/SHOOK Top Advisor Summit
The SHOOK community is funding a lifesaving cancer treatment for kids who have run out of options
Donate NowCCRF offers a variety of options to pledge your support:
Meet Leo and Lily. Both are facing one of the deadliest forms of cancer: relapsed high-risk neuroblastoma. Kids with this type of cancer face a less than 5% chance of survival. Until now, there were no proven treatment options left for kids like Leo and Lily.
Thanks to the SHOOK community, kids like Leo and Lily now have hope of being cured with new immunotherapies in clinical trial. In fact, Leo will be receiving his first treatment on October 3, 2023—the first day of the Forbes/SHOOK Top Advisor Summit. This is a potentially lifesaving immunotherapy, and we’ll make sure it’s safe, healthy and available to children who need it.
Donor Benefits
Your donation will help:
- Enable this treatment to be available for kids who have no other options.
- Break the limits of current immunotherapies, making it safer and more effective for kids.
- Lay the groundwork so scientists can use the therapy for other childhood cancers, too.
- Allow children and families to travel to the treatment without the burden of expense.
Above: Dr. John Maris
Meet Dr. Maris
John M. Maris, MD, is a pediatric oncologist at Children's Hospital of Philadelphia, co-head of the Pediatric Cancer Dream Team and holds the Giulio D'Angio Chair in Neuroblastoma Research.
Dr. Maris created the first-in-human, first-in-child clinical trial using a new class of cellular immunotherapies for neuroblastoma patients like Leo and Lily.
To make a donation over the phone please contact:
Kenna Dooley - Director of Development and Donor Relations
952-224-8486
1650 W 82nd St., Suite 400
Minneapolis, MN 55431
Social Media Toolkit
Together with SHOOK Research, we are funding a lifesaving cancer treatment for kids who have run out of options.
Let's spread the word.
The Social Media Toolkit provides graphics and sample captions for sharing that you are/your company is partnering with Shook Research and Children’s Cancer Research Fund to fund a lifesaving treatment for kids with relapsed high-risk neuroblastoma.
By sharing this cause with your community, you can maximize the impact of your gift—and let kids facing this deadly disease know they are not alone.
Advisors must receive proper approval from their firm before use.
